These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

184 related articles for article (PubMed ID: 31770548)

  • 1. Health Care Disparities in Urologic Oncology: A Systematic Review.
    Das H; Rodriguez R
    Urology; 2020 Feb; 136():9-18. PubMed ID: 31770548
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Potential role for metformin in urologic oncology.
    Sayyid RK; Fleshner NE
    Investig Clin Urol; 2016 May; 57(3):157-64. PubMed ID: 27195314
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Perspectives on Geriatric Oncology Research presented at the 2019 American Society of Clinical Oncology Genitourinary Cancers Symposium.
    Shen J; Prentice M; Pollock Y; Franca M; Kanesvaran R
    J Geriatr Oncol; 2019 Jul; 10(4):523-525. PubMed ID: 30982753
    [No Abstract]   [Full Text] [Related]  

  • 4. Open clinical uro-oncology trials in Canada.
    Mackenzie M; Rodrigues G; Winquist E
    Can J Urol; 2007 Aug; 14(4):3662-7. PubMed ID: 17784993
    [No Abstract]   [Full Text] [Related]  

  • 5. Contemporary Systemic Therapy for Urologic Malignancies in Geriatric Patients.
    Zhao B; Grivas PD
    Clin Geriatr Med; 2015 Nov; 31(4):645-65. PubMed ID: 26476122
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Update on the medical treatment of urologic tumors].
    Culine S
    Bull Cancer; 2000 Jan; 87(1):71-5. PubMed ID: 10673634
    [No Abstract]   [Full Text] [Related]  

  • 7. New Insights into Diagnosis and Treatment of Renal Cell Carcinoma, Bladder Cancer, and Prostate Cancer.
    Chlosta PL; Golabek T; Nyirády P
    Biomed Res Int; 2017; 2017():6467072. PubMed ID: 28386561
    [No Abstract]   [Full Text] [Related]  

  • 8. Genitourinary malignancy.
    Hudes GR; Ozols RF; Giantonio B
    Cancer Chemother Biol Response Modif; 1994; 15():531-54. PubMed ID: 7779598
    [No Abstract]   [Full Text] [Related]  

  • 9. [Update uro-oncology: scientific meetings 2011].
    Hegele A; Skrobek L; Schrader AJ
    Aktuelle Urol; 2012 Jan; 43(1):13-27. PubMed ID: 22344822
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Urologic cancer in Thailand.
    Lojanapiwat B
    Jpn J Clin Oncol; 2015 Nov; 45(11):1007-15. PubMed ID: 26355159
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Urologic cancer in Indonesia.
    Umbas R; Safriadi F; Mochtar CA; Djatisoesanto W; Hamid AR
    Jpn J Clin Oncol; 2015 Aug; 45(8):708-12. PubMed ID: 26085688
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The role of immunotherapy in urologic malignancies.
    Abubakr YA; Redman BG
    Cancer Treat Res; 1996; 88():235-48. PubMed ID: 9239484
    [No Abstract]   [Full Text] [Related]  

  • 13. An assessment of the current use of human interferons in therapy of urological cancers.
    Horoszewicz JS; Murphy GP
    J Urol; 1989 Nov; 142(5):1173-80. PubMed ID: 2478725
    [No Abstract]   [Full Text] [Related]  

  • 14. The role of immunotherapy for urological tumours.
    Hrouda D; Muir GH; Dalgleish AG
    Br J Urol; 1997 Mar; 79(3):307-16. PubMed ID: 9117206
    [No Abstract]   [Full Text] [Related]  

  • 15. Urologic Pathology: Key Parameters from a Urologist's Perspective.
    Borchert A; Rogers CG
    Surg Pathol Clin; 2018 Dec; 11(4):893-901. PubMed ID: 30447847
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The role of imaging in the surveillance of urologic malignancies.
    Bradford TJ; Montie JE; Hafez KS
    Urol Clin North Am; 2006 Aug; 33(3):377-96. PubMed ID: 16829272
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Applications of spectroscopy in diagnosis, staging, and treatment of urologic malignancies.
    Seltz LM; Herrell SD
    Curr Opin Urol; 2016 May; 26(3):259-63. PubMed ID: 26914060
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [The studies of natural killer cell activity in uro-genital cancer patients--investigation of natural killer cell activity from the standpoint of stage and antitumor therapy of genito-urinary tract carcinomas].
    Fukasawa K
    Nihon Hinyokika Gakkai Zasshi; 1988 Feb; 79(2):239-45. PubMed ID: 3226000
    [No Abstract]   [Full Text] [Related]  

  • 19. [DGFIT: Immune and targeted therapy in urologic oncology – what can be expected?].
    Hegele A; Heinzer H; Rüttinger D; Siebels M
    Aktuelle Urol; 2012 Jul; 43(4):219-26. PubMed ID: 23035262
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Genitourinary cancer.
    Hudes GR; Grana G; Deshields MS; Ozols RF
    Cancer Chemother Biol Response Modif; 1992; 13():508-40. PubMed ID: 1389919
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 10.